MindFrame, Inc.: Series A $6M

Posted in I - Series A, Q - 2Q08, R - WEST, X - Device (Neuromod), X - Ischemia, X - Neurology, X - Stroke

MindFrame (Lake Forrest, CA) developer of devices for ischemic stroke treatment, closed a $6M Series A financing. Participants include SV Life Sciences and Intersect Partners.

Nov

2008

Aldagen, Inc.: Series D $18.4M

Posted in I - Series D, Q - 2Q08, R - SOUTH EAST, X - Ischemia, X - Leukemia, X - Metabolism, X - Stem Cell

Aldagen (Durham, NC) development-stage biopharmaceutical company focused on regenerative cell therapies, closed a $18.M Series D financing. Participants include Intersouth Partners, Tullis-Dickerson, Harbert Venture Partners, and The Aurora Funds.

Nov

2008

CoAxia, Inc.: Series C $11.5M

Posted in I - Series C, Q - 2Q08, R - MID WEST, X - Device (Catheter), X - Drug:Device Combo, X - Ischemia

CoAxia (Maple Grive, MN) development-stage medical device company focused on a catheter-based therapy for cerebral ischemia, closed a $11.5M Series C financing. Participants include Canaan Partners, Prism Venture Partners, Baird Venture Partners, Affinity Capital Management, Johnson and Johnson Development Corporation and SVB Capital Partners.

to top of page...